Faecal Microbiome Transplants and Brain Plasticity in Mice

Recent research published in 2026 indicates that faecal microbiome transplants (FMT) from young mice can restore brain plasticity in older adult mice. By manipulating the gut microbiome, researchers successfully enabled adult mice to overcome conditions similar to amblyopia, a visual impairment typically treatable only during childhood development. This discovery highlights the gut-brain axis as a critical regulator of neural circuit maturation and suggests that the microbiome acts as an active partner in brain development alongside genetic and environmental factors. The study, led by Paola Tognini, demonstrates that the gut microbiome influences gene expression in the visual cortex, specifically affecting myelination and blood-brain barrier permeability. Antibiotic-induced depletion of gut bacteria in young mice was shown to inhibit neuroplasticity, while the introduction of young microbiota into adult mice effectively rejuvenated their brain's ability to remodel neural connections. This suggests that the microbiome plays a foundational role in defining the windows of heightened plasticity throughout an organism's lifespan. The findings imply that targeting specific microbial metabolites or strains could eventually offer therapeutic avenues for enhancing learning, recovery from brain injuries, and resilience against age-related neurological decline in humans. However, experts caution that direct translation to human clinical practice remains premature due to the complexity of human brains and the significant influence of diet and lifestyle on the microbiome. For practitioners and researchers, this study underscores the necessity of judicious antibiotic use during critical developmental windows. Future applications may involve personalized microbiome interventions to support cognitive health, though identifying the precise microbial mechanisms responsible for these neuroplastic effects remains a primary challenge for the scientific community.